{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:10:23Z","timestamp":1776280223761,"version":"3.50.1"},"reference-count":10,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,5]]},"DOI":"10.1182\/blood.2023021311","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:30:22Z","timestamp":1696519822000},"page":"1178-1180","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Birtamimab: a new amyloidosis treatment?"],"prefix":"10.1182","volume":"142","author":[{"given":"Antoine","family":"Huart","sequence":"first","affiliation":[{"name":"University Hospital of Toulouse"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"14","key":"2023100515301731300_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2022019406","article-title":"Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial","volume":"142","author":"Gertz","year":"2023","journal-title":"Blood"},{"issue":"9","key":"2023100515301731300_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023100515301731300_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl","key":"2023100515301731300_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.HS9.0000846528.55550.9c","article-title":"P915: Efficacy and safety of daratumumab monotherapy in newly diagnosed patients with stage 3b light chain amyloidosis: a phase 2 study by the European Myeloma Network","volume":"6","author":"Kastritis","year":"2022","journal-title":"HemaSphere"},{"issue":"3","key":"2023100515301731300_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V86.3.855.855","article-title":"New drug therapy of amyloidoses: resorption of AL type deposits with 4-iodo-4-deoxydoxorubicin","volume":"86","author":"Gianni","year":"1995","journal-title":"Blood"},{"issue":"8","key":"2023100515301731300_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00392-010-0142-x","article-title":"Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis","volume":"99","author":"Mereles","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"2023100515301731300_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12872-021-02407-6","article-title":"Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study","volume":"22","author":"Wechalekar","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"2023100515301731300_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/13506129.2016.1205974","article-title":"2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis (dagger)","volume":"23","author":"Renz","year":"2016","journal-title":"Amyloid"},{"issue":"12","key":"2023100515301731300_bib9","doi-asserted-by":"crossref","first-page":"e52686","DOI":"10.1371\/journal.pone.0052686","article-title":"AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on\u00a0amyloid fibrils","volume":"7","author":"Wall","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"2023100515301731300_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1200\/JCO.2015.63.6530","article-title":"First-in-human phase I\/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction","volume":"34","author":"Gertz","year":"2016","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/14\/1178\/2083215\/blood_bld-2023-021311-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/14\/1178\/2083215\/blood_bld-2023-021311-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:30:29Z","timestamp":1696519829000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/14\/1178\/498145\/Birtamimab-a-new-amyloidosis-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":10,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,10,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023021311","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}